Hunt, N. B., Pajouheshnia, R. ., Salih, A. ., van Doorn, S. ., Souverein, P. C., Bazelier, M. T., … Gardarsdottir, H. . (2023). Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15708
S. van Doorn
First name
S.
Last name
van Doorn
van den Dries, C. J., Pajouheshnia, R. ., van den Ham, H. A., Souverein, P. ., Moons, K. G. M., Hoes, A. W., … van Doorn, S. . (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15534
van den Dries, C. J., van Doorn, S. ., Souverein, P. ., Pajouheshnia, R. ., Moons, K. G. M., Hoes, A. W., … van den Ham, H. A. (2020). The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open. http://doi.org/10.1055/s-0040-1721499